KRAS and neoplasm: The translational rationale is straightforward: KRAS-mutant LGSOC often relies on chronic MAPK signaling for proliferation and survival, so simultaneous and persistent suppression of RAF → MEK signaling should produce deeper and more durable tumor control than MEK inhibition alone.